Most Read Articles
Natalia Reoutova, 07 Jul 2020

A hospital-based observational cohort study finds an association between higher fasting blood glucose (FBG) levels and unfavourable outcomes, including death, among Chinese patients with diabetes mellitus (DM) following acute ischaemic stroke (AIS).

Dapagliflozin: Innovation in managing heart failure

26 May 2020
In an AstraZeneca symposium entitled “Diabetes Respiratory Academy” held on 19 October 2019 at the Dusit Hotel Makati, specialists in the fields of cardiology and research discussed the new updates in the management of patients with type 2 diabetes (T2D) and the promising evidence on the use of sodium-glucose cotransporter-2 (SGLT-2) inhibitors in the management of patients with heart failure.

Related MIMS Drugs

Editor's Recommendations
Most Read Articles
Natalia Reoutova, 07 Jul 2020

A hospital-based observational cohort study finds an association between higher fasting blood glucose (FBG) levels and unfavourable outcomes, including death, among Chinese patients with diabetes mellitus (DM) following acute ischaemic stroke (AIS).